Naoto Gotohda

National Cancer Center Hospital East

Papers

2

Total Citations

37

H-Index

2

About

Dr. Naoto Gotohda is a leading hepatobiliary and pancreatic surgeon whose research focuses on advancing minimally invasive surgical techniques for liver and pancreatic cancers. He has made pivotal contributions to standardizing complex procedures, most notably through his work on minimally invasive anatomic liver resection (MIALR). His 2021 survey of world experts, which has garnered 28 citations, provided critical insights into the current state and challenges of MIALR, helping to shape best practices and future research directions. Dr. Gotohda is also at the forefront of pancreatic cancer surgery, serving as the principal investigator for the landmark JCOG2202 (LAPAN study), a multi-institutional randomized phase III trial comparing minimally invasive distal pancreatectomy (MIDP) to open surgery. This study, published in 2024 with 9 citations, addresses the crucial question of oncologic safety in MIDP, a procedure that has rapidly gained popularity. Through these high-impact studies, Dr. Gotohda is instrumental in generating the evidence needed to safely expand the role of minimally invasive surgery in oncology, directly influencing surgical standards and improving patient outcomes.

Research Focus

Key Achievements

2
H-Index
2
Papers
37
Total Citations
19
Avg Citations/Paper
🏆 Most Cited Paper
Minimally invasive anatomic liver resection: Results of a survey of world experts
28 citations · 2021
📈 Most Prolific Year: 2021 (1 Papers)
🤝 Key Collaborators: 84
🏛 Institutions: National Cancer Center Hospital East

Top Papers

  1. 1
  2. 2

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 13 days ago